secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001628280-26-031649
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem Q1 net rev $33.7M (-3% YoY); net income $1.0M vs prior loss
----------------------------------------------------------------------

- Patient Services rev $22.1M (+6% YoY); wound care revenue more than doubled to $2.1M.
- Device Solutions rev $11.6M (-17% YoY) due to GE Healthcare contract restructure.
- Gross margin expanded to 58.4% from 55.2%; adjusted EBITDA $6.4M (18.9% margin).
- Full-year 2026 guidance reaffirmed: pro-forma net rev growth 6-8%, adj EBITDA margin mid-to-low 20%.
- Repurchased $856k of common stock; liquidity $57.1M; new ERP went live March 1, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828026031649/0001628280-26-031649-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828026031649/infu-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-031649

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer